Upexi (DB:7TQ0) - Stock Price, News & Analysis

7TQ0 Stock Overview

Manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets.

7TQ0 fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Rewards

Trading at good value compared to peers and industry

Risk Analysis

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€8M)

Has less than 1 year of cash runway

Currently unprofitable and not forecast to become profitable over the next 3 years

+ 1 more risk

Upexi, Inc. Competitors

NutryFarm International

SGX:AZT

S$11.7m

Shineco

NasdaqCM:SISI

US$4.6m

BillionsLtd

KOSDAQ:A044480

₩23.4b

Martina Berto

IDX:MBTO

Rp110.2b

Price History & Performance

Summary of all time highs, changes and price drops for Upexi
Historical stock prices
Current Share Price	US$2.92
52 Week High	US$23.80
52 Week Low	US$2.50
Beta	0.45
11 Month Change	0%
3 Month Change	-29.81%
1 Year Change	-84.71%
33 Year Change	-96.71%
5 Year Change	n/a
Change since IPO	-97.14%

Recent updates

Shareholder Returns

	7TQ0	DE Personal Products	DE Market
7D	0%	-2.3%	-1.8%
1Y	-84.7%	0.6%	13.6%

Return vs Industry: 7TQ0 underperformed the German Personal Products industry which returned 0.6% over the past year.

Return vs Market: 7TQ0 underperformed the German Market which returned 13.2% over the past year.

Price Volatility

Is 7TQ0's price volatile compared to industry and market?
7TQ0 volatility
7TQ0 Average Weekly Movement	15.6%
Personal Products Industry Average Movement	3.8%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.5%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 7TQ0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 7TQ0's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
2018	95	Allan Marshall	www.upexi.com

Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.

Upexi, Inc. Fundamentals Summary

How do Upexi's earnings and revenue compare to its market cap?
7TQ0 fundamental statistics
Market cap	€7.75m
Earnings (TTM)	-€21.15m
Revenue (TTM)	€77.50m

0.1x

P/S Ratio

-0.4x

P/E Ratio

Is 7TQ0 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7TQ0 income statement (TTM)
Revenue	US$83.98m
Cost of Revenue	US$54.43m
Gross Profit	US$29.55m
Other Expenses	US$52.47m
Earnings	-US$22.92m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-21.94
Gross Margin	35.19%
Net Profit Margin	-27.29%
Debt/Equity Ratio	120.9%

How did 7TQ0 perform over the long term?

See historical performance and comparison

7TQ0 Stock Overview

Rewards

Risk Analysis

Upexi, Inc. Competitors

SGX:AZT

S$11.7m

NasdaqCM:SISI

US$4.6m

KOSDAQ:A044480

₩23.4b

IDX:MBTO

Rp110.2b

Price History & Performance

Recent News & Updates

Upexi, Inc. to Report Fiscal Year 2024 Results on Nov 01, 2024

Nasdaq Grants Additional 180 Days to Upexi to Regain Compliance with Minimum Bid Price Requirement

Upexi, Inc. announced delayed annual 10-K filing

Insufficient new directors

David Romano, Nick Romano and Eric Limont acquired E-Core, Inc from Upexi, Inc. (NasdaqCM:UPXI) for $2 million.

E-Core Holdings, LLC acquired E-Core, Inc from Upexi, Inc. (NasdaqCM:UPXI) for $2 million.

Recent updates

Upexi, Inc. to Report Fiscal Year 2024 Results on Nov 01, 2024

Nasdaq Grants Additional 180 Days to Upexi to Regain Compliance with Minimum Bid Price Requirement

Upexi, Inc. announced delayed annual 10-K filing

Insufficient new directors

David Romano, Nick Romano and Eric Limont acquired E-Core, Inc from Upexi, Inc. (NasdaqCM:UPXI) for $2 million.

E-Core Holdings, LLC acquired E-Core, Inc from Upexi, Inc. (NasdaqCM:UPXI) for $2 million.

Upexi Provides Update on Filing Form 10Q for March 31, 2024

Upexi, Inc. to Report Q3, 2024 Results on Jun 24, 2024

MFA Holdings Corp., 1000915944 Ontario Inc and Nutraproducts LLC acquired VitaMedica Corporation from Upexi, Inc. (NasdaqCM:UPXI) for $6 million.

Upexi, Inc. announced delayed 10-Q filing

Upexi, Inc., Annual General Meeting, Jun 10, 2024

New major risk - Market cap size

Upexi Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on the Nasdaq Capital Market Under Nasdaq Listing Rule 5550(a)(2)

Second quarter 2024 earnings released: US$0.12 loss per share (vs US$0.17 profit in 2Q 2023)

Insufficient new directors

Upexi, Inc. Revises Preliminary and Unaudited Financial Guidance for the First Quarter Ended September 30, 2023

Upexi, Inc. Pet Care Brand, Luckytail, Announces Expansion of Product Line to Include All-Natural Dog Supplements

Amplifyir Inc. acquired 100% stake in Interactive Offers LLC from Upexi, Inc. (NasdaqCM:UPXI) for $1.25 million.

New major risk - Share price stability

Upexi, Inc., Annual General Meeting, Jun 26, 2023

Third quarter 2023 earnings released: US$0.11 loss per share (vs US$0.003 loss in 3Q 2022)

Upexi, Inc. announced delayed 10-Q filing

Second quarter 2023 earnings released: EPS: US$0.17 (vs US$0.004 in 2Q 2022)

CEO, President & Chairman of the Board recently bought €70k worth of stock

First quarter 2023 earnings released: US$0.15 loss per share (vs US$0.033 profit in 1Q 2022)

High number of new and inexperienced directors

Grove, Inc. (NasdaqCM:GRVI) completed the acquisition of E-Core, Inc.

Bloomios, Inc. (OTCPK:BLMS) acquired Infusionz, LLC from Upexi, Inc. (NasdaqCM:UPXI) for $23.5 million.

Upexi, Inc. Files Patent for its Single Click-to-optin Technology

Upexi, Inc. Provides Revenue Guidance for the Fiscal Year 2023

Full year 2022 earnings released: US$0.13 loss per share (vs US$0.25 profit in FY 2021)

Upexi, Inc. Appoints Anthony Bazan as Chief Operating Officer

Investor sentiment deteriorated over the past week

Grove, Inc. (NasdaqCM:GRVI) signed a non-binding LOI to acquire E-Core, Inc.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Grove, Inc.(NasdaqCM:GRVI) dropped from Russell Microcap Value Index

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Grove, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings released: US$0.003 loss per share (vs US$0.071 profit in 3Q 2021)

High number of new and inexperienced directors

Grove, Inc. (NasdaqCM:GRVI) acquired Cygnet Online LLC.

Grove, Inc., Annual General Meeting, May 24, 2022

Investor sentiment improved over the past week

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS US$0.033 (vs US$0.078 loss in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS US$0.25 (vs US$0.53 loss in FY 2020)

Grove, Inc. (NasdaqCM:GRVI) signed a letter of intent to acquire Interactive Offers LLC.

Grove, Inc. (NasdaqCM:GRVI) completed the acquisition of VitaMedica Corporation.

Shareholder Returns

Price Volatility

About the Company

Upexi, Inc. Fundamentals Summary

0.1x